Marketing & Sales | ABNewswire

Learning More About the Advantages of Alkaline Batteries

What are the advantages of Alkaline Batteries, let Kamada Power share the experience today. In today’s era dominated by handheld devices, batteries play an indispensable role. While smartphones often take center stage, it’s important not to overlook the unsung heroes behind countless … Continue reading →

Limbal Stem Cells Deficiency Market 2032: Epidemiology Overview, Therapeutic Innovations, Regulatory Progress by DelveInsight | Kala Pharma, CLIPS BnC Co., RHEACELL GmbH, Holostem Terapie Avanzate

The Limbal Stem Cells Deficiency Market size was valued approximately USD 2,668 million in 2022 and the report offers an in-depth understanding of the Limbal Stem Cells Deficiency, historical and forecasted epidemiology as well as the Limbal Stem Cells Deficiency … Continue reading →

Synovial Sarcoma Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | EpiZyme, Merck & Co, Immunocore, Johnson & Johnson, Karyopharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Synovial Sarcoma pipeline constitutes 15+ key companies continuously working towards developing 20+ Synovial Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

AKPKD Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Galapagos NV, Reata Pharma, Kadmon Pharma, Sanofi, Anakuria Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Autosomal Dominant Polycystic Kidney Disease pipeline constitutes 12+ key companies continuously working towards developing 12+ Autosomal Dominant Polycystic Kidney Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, … Continue reading →

High-Grade Glioma Pipeline Assessment, 2024 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Chimerix, BioMimetix

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, High-Grade Glioma pipeline constitutes 150+ key companies continuously working towards developing 150+ High-Grade Glioma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Neuroblastoma Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Aum Bio, NanoPharma, Athenex, Actuate Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Neuroblastoma pipeline constitutes 35+ key companies continuously working towards developing 35+ Neuroblastoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The … Continue reading →

Friedreich’s Ataxia Pipeline Assessment, 2024 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | AbbVie, Minoryx Therapeutics, Takeda

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Friedreich’s Ataxia pipeline constitutes 10+ key companies continuously working towards developing 10+ Friedreich’s Ataxia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Hepatitis C Market Forecast 2032: FDA, EMA, PDMA Approvals, Epidemiology, Therapies, Clinical Trials and Companies by DelveInsight | BMS, Merck, Roche, Gilead Sciences, Johnson & Johnson, Abbvie

Hepatitis C Market Hepatitis C companies are GeneCure Biotechnologies, Biotron, Cocrystal Pharma, Genecure Biotechnologies Preclinical, iQur, Atea Pharmaceutical, Dongguan HEC TaiGen Biopharmaceuticals, and Nanjing Sanhome Pharmaceutical, Bristol-Myers Squibb Company, Merck & Co., Inc., F Hoffmann-La Roche Ltd, Gilead Sciences, Inc., … Continue reading →

Chemotherapy Induced Anemia Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Drugs, Epidemiology and Companies by DelveInsight | Roxadustat (FG-4592), ALRN-6924, Desidustat

Chemotherapy Induced Anemia Market Chemotherapy Induced Anemia companies are Astellas, FibroGen, AstraZeneca, Aileron Therapeutics, Zydus Cadila, Pfizer Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Amgen Inc., Novartis AG, 3SBio Group, Bristol-Myers Squibb, FibroGen, and others. (Albany, USA) DelveInsight’s “Chemotherapy … Continue reading →

Balloon Catheters Market is expected to grow at a CAGR of 8.78% by 2030, estimates DelveInsight

Balloon Catheters Market Balloon Catheters companies are Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical … Continue reading →

Friday - May 10, 2024

Category Archives: Marketing & Sales